Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Integrated Core Strategies (US) LLC reported a 5.70% stake in Karyopharm Therapeutics Inc. (Schedule 13G)

Event Aug 31, 2026 · Filed Sep 4, 2026

Integrated Core Strategies (US) LLC reported a 5.70% stake in Karyopharm Therapeutics Inc., 1,297,297 shares, as a passive investor on Aug 31, 2026. Filed Sep 4, 2026 (Schedule 13G).

Stake
5.70%
Shares
1,297,297
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC5.70%1,297,297
Millennium Management LLC5.70%1,297,297
Millennium Group Management LLC5.70%1,297,297
Israel A. Englander5.70%1,297,297

Source

View original at SEC

Related